Share:
Share this content in WeChat
X
• Review •
Research progress on MRI assessment of extramural vascular invasion in rectal cancer
OU Yanghong  WEI Zhaokun  WANG Lili  JIA Yingmei 

DOI:10.12015/issn.1674-8034.2026.11.025.


[Abstract] Extramural vascular invasion (EMVI) is an independent risk factor for local recurrence, distant metastasis, and reduced overall survival in patients with rectal cancer (RC).Accurate preoperative MRI assessment is of considerable clinical value for individualized treatment decision-making. This review summarizes recent advances in MRI-based assessment of RC EMVI, with a particular focus on the latest applications of radiomics and artificial intelligence (AI), and discusses their strengths and limitations. It aims to provide critical imaging evidence for formulating individualized clinical treatment strategies and to offer new diagnostic perspectives for precision medicine. Quantitative imaging and AI are shifting EMVI assessment from morphology-based description to precise quantification, offering more reliable imaging evidence for individualized management. Looking ahead, with the ongoing accumulation of multiparametric MRI data and continued advances in AI, the integration of radiomics and AI is likely to be further strengthened. In particular, the multidimensional integration of imaging, clinical, and biological information may represent a promising pathway to facilitate the clinical translation of precision medicine in RC, ultimately contributing to more effective and individualized patient care.
[Keywords] rectal cancer;extramural vascular invasion;magnetic resonance imaging;diffusion-weighted imaging;radiomics;artificial intelligence

OU Yanghong   WEI Zhaokun   WANG Lili   JIA Yingmei*  

Department of Radiology, Gansu Province Hospital, Lanzhou 730000, China

Corresponding author: JIA Y M, E-mail: jiaym28@163.com

Conflicts of interest   None.

Received  2026-04-29
Accepted  2026-10-15
DOI: 10.12015/issn.1674-8034.2026.11.025
DOI:10.12015/issn.1674-8034.2026.11.025.

[1]
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. DOI: 10.3322/caac.21834.
[2]
HAN B F, ZHENG R S, ZENG H M, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53. DOI: 10.1016/j.jncc.2024.01.006.
[3]
LI X M, ZHOU Y F, WANG A Y, et al. Prediction of treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer by interpretable model based on multiparametric MRI[J]. Chin J Magn Reson Imaging, 2026, 17(1): 59-68, 122. DOI: 10.12015/issn.1674-8034.2026.01.009.
[4]
CRIMÌ F, ANGELONE R, CORSO A, et al. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?[J]. Eur Radiol, 2023, 33(10): 6852-6860. DOI: 10.1007/s00330-023-09655-4.
[5]
MASSUCCO P, FONTANA A P, BALBO MUSSETTO A, et al. MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer[J]. J Surg Oncol, 2022, 125(6): 1024-1031. DOI: 10.1002/jso.26818.
[6]
TANG C, XU J M, XU J L, et al. MRI and related basic research progress of extramural vascular invasion of rectal cancer[J]. J Clin Radiol, 2023, 42(11): 1847-1850.
[7]
GAO W, LIU A S, WANG Z F, et al. Research advances in imaging evaluation of extramural vascular invasion of rectal cancer[J]. Chin J Dig Surg, 2021, 20(3): 355-358. DOI: 10.3760/cma.j.cn115610-20210201-00054.
[8]
LIU Y P, YI W Z, DING R. Research progress of multimodal imaging in diagnosis of extramural vascular invasion in rectal cancer[J]. J Med Imaging, 2023, 33(1): 131-134. DOI: 10.20258/j.cnki.1006-9011.2023.01.031.
[9]
XIE Y Y, PENG K. Research progress of quantitative MRI in preoperative evaluation of extramural vascular invasion of rectal cancer[J]. Int J Med Radiol, 2023, 46(3): 308-312. DOI: 10.19300/j.2023.Z20183.
[10]
LAL N, CHEONG CHUNG K J N, HODGES N, et al. Prognostic significance of post-neoadjuvant MRI-detected extramural venous invasion and tumour deposits in rectal cancer: a systematic review and meta-analysis[J/OL]. Eur J Surg Oncol, 2026, 52(6): 111840 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/42048918. DOI: 10.1016/j.ejso.2026.111840.
[11]
FENG Y R, HU T D, GU W C, et al. Mesorectal Fascia Involvement by tumor deposits or extramural vascular invasion at MRI predicts prognosis in rectal cancer[J/OL]. Radiology, 2025, 317: e243627 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/41147908. DOI: 10.1148/radiol.243627.
[12]
ROULEAU FOURNIER F, MOTAMEDI M A K, BROWN C J, et al. Oncologic outcomes associated with MRI-detected extramural venous invasion (mrEMVI) in rectal cancer: A systematic review and meta-analysis[J]. Ann Surg, 2022, 275(2): 303-314. DOI: 10.1097/SLA.0000000000004636.[PubMed]
[13]
BHUTIANI N, YOUSEF M M, YOUSEF A M, et al. Does extramural vascular invasion predict response to neoadjuvant therapy in locally advanced rectal cancer?[J]. Clin Colorectal Cancer, 2025, 24(2): 272-279. DOI: 10.1016/j.clcc.2025.02.002.
[14]
AYUSO J R, BALYANISKOVA S, BEETS-TAN R G H, et al. MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART I primary staging[J]. Eur Radiol, 2026, 36(6): 4592-4607. DOI: 10.1007/s00330-025-12274-w.
[15]
KIM T H, WOO S, HAN S, et al. The diagnostic performance of MRI for detection of extramural venous invasion in colorectal cancer: a systematic review and meta-analysis of the literature[J]. Am J Roentgenol, 2019, 213(3): 575-585. DOI: 10.2214/ajr.19.21112.
[16]
SOFIC A, HUSIC-SELIMOVIC A, EFENDIC A, et al. MRI evaluation of extramural venous invasion (EMVI) with rectal carcinoma using high resolution T2 and combination of high resolution T2 and contrast enhanced T1 weighted imaging[J]. Acta Inform Med, 2021, 29(2): 113-117. DOI: 10.5455/aim.2021.29.113-117.
[17]
AHN J H, KIM S H, SON J H, et al. Added value of diffusion-weighted imaging for evaluation of extramural venous invasion in patients with primary rectal cancer[J/OL]. Br J Radiol, 2019, 92(1096): 20180821 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/30698998. DOI: 10.1259/bjr.20180821.
[18]
TAN J J, CARTEN R V, BABIKER A, et al. Prognostic importance of MRI-detected extramural venous invasion in rectal cancer: A literature review and systematic meta-analysis[J]. Int J Radiat Oncol Biol Phys, 2021, 111(2): 385-394. DOI: 10.1016/j.ijrobp.2021.05.136.
[19]
AYUSO J R, BALYANISKOVA S, BEETS-TAN R G H, et al. MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART Ⅱ: Restaging and response evaluation[J]. Eur Radiol, 2026, 36(6): 4608-4621. DOI: 10.1007/s00330-025-12275-9.
[20]
AO W Q, ZHANG X, YAO X Z, et al. Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study[J/OL]. BMC Med Imaging, 2022, 22(1): 78 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/35484509. DOI: 10.1186/s12880-022-00810-9.
[21]
WANG K X, YU J, XU Q. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging to predict extramural venous invasion in rectal cancer[J/OL]. BMC Med Imaging, 2023, 23(1): 77 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/37291527. DOI: 10.1186/s12880-023-01027-0.
[22]
CHAI Y X, NIU Y C, CHENG R X, et al. Dynamic contrast-enhanced MRI combined with intravoxel incoherent motion in quantitative evaluation for preoperative risk stratification of resectable rectal adenocarcinoma[J/OL]. Oncol Lett, 2025, 29(2): 68 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/39619420. DOI: 10.3892/ol.2024.14814.
[23]
TAO J, YIN Z Z, LI X W, et al. Correlation between IVIM parameters and microvessel architecture: direct comparison of MRI images and pathological slices in an orthotopic murine model of rhabdomyosarcoma[J]. Eur Radiol, 2023, 33(12): 8576-8584. DOI: 10.1007/s00330-023-09835-2.
[24]
ZHOU M, CHEN M Y, LUO M F, et al. Pathological prognostic factors of rectal cancer based on diffusion-weighted imaging, intravoxel incoherent motion, and diffusion kurtosis imaging[J]. Eur Radiol, 2025, 35(2): 979-988. DOI: 10.1007/s00330-024-11025-7.
[25]
GAO F, SHI B, WANG P P, et al. The value of intravoxel incoherent motion diffusion-weighted magnetic resonance imaging combined with texture analysis of evaluating the extramural vascular invasion in rectal adenocarcinoma[J/OL]. Front Oncol, 2022, 12: 813138 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/35311135. DOI: 10.3389/fonc.2022.813138.
[26]
KAN S J, SUN Y W, AI K, et al. Correlation of pathologic features and prognostic factors in rectal adenocarcinoma based on APT imaging and IVIM-DWI histogram[J/OL]. Magn Reson Imaging, 2025, 122: 110430 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/40456335. DOI: 10.1016/j.mri.2025.110430.
[27]
CHEN W C, WEI Q R, HUANG W K, et al. Combining diffusion kurtosis imaging and clinical data for predicting the extramural venous invasion of rectal adenocarcinoma[J/OL]. Eur J Radiol, 2022, 148: 110155 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/35045353. DOI: 10.1016/j.ejrad.2022.110155.
[28]
MENG N, HUANG Z, JIANG H, et al. Glucose chemical exchange saturation transfer MRI for predicting the histological grade of rectal cancer: a comparative study with amide proton transfer-weighted and diffusion-weighted imaging[J/OL]. Insights Imaging, 2024, 15(1): 269 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/39527162. DOI: 10.1186/s13244-024-01828-z.
[29]
ZHANG L, LI L C, REN Z J, et al. Added value of 3D APT histogram analysis to DWI for predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J/OL]. Eur J Radiol, 2026, 194: 112478 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/41115362. DOI: 10.1016/j.ejrad.2025.112478.
[30]
DU Y X, XU W X, HE Y Q, et al. Amide proton transfer weighted and diffusion-weighted imaging in evaluating rectal cancer tumor budding grade value[J]. Chin J Magn Reson Imaging, 2025, 16(1): 42-47, 73. DOI: 10.12015/issn.1674-8034.2025.01.007.
[31]
CHEN W C, LI L, YAN Z X, et al. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging[J]. Eur Radiol, 2021, 31(5): 3286-3296. DOI: 10.1007/s00330-020-07397-1.
[32]
LI J, LIN L J, GAO X M, et al. Amide proton transfer weighted and intravoxel incoherent motion imaging in evaluation of prognostic factors for rectal adenocarcinoma[J/OL]. Front Oncol, 2021, 11: 783544 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/35047400. DOI: 10.3389/fonc.2021.783544.
[33]
CHEN W C, LIU G Q, CHEN J L, et al. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study[J]. Eur Radiol, 2023, 33(7): 5159-5171. DOI: 10.1007/s00330-023-09418-1.
[34]
CHEN Z H, ZHANG M Y, WANG M J, et al. Research progress of synthetic MRI in clinical diseases[J]. Chin J Magn Reson Imaging, 2025, 16(7): 227-234. DOI: 10.12015/issn.1674-8034.2025.07.036.
[35]
LI M Q, FU W H, OUYANG L Y, et al. Potential clinical feasibility of synthetic MRI in bladder tumors: a comparative study with conventional MRI[J]. Quant Imaging Med Surg, 2023, 13(8): 5109-5118. DOI: 10.21037/qims-22-1419.
[36]
WANG Z, DAI Z Z, ZHOU X Y, et al. Synthetic double inversion recovery imaging for rectal cancer T staging evaluation: imaging quality and added value to T2-weighted imaging[J]. Insights Imaging, 2024, 15(1): 256 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/39446274. DOI: 10.1186/s13244-024-01796-4.
[37]
ZHU K X, CHEN Z C, CUI L L, et al. The preoperative diagnostic performance of multi-parametric quantitative assessment in rectal carcinoma: a preliminary study using synthetic magnetic resonance imaging[J/OL]. Front Oncol, 2022, 12: 682003 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/35707367. DOI: 10.3389/fonc.2022.682003.
[38]
ZHAO L, LIANG M, XIE L Z, et al. Prediction of pathological prognostic factors of rectal cancer by relaxation maps from synthetic magnetic resonance imaging[J/OL]. Eur J Radiol, 2021, 138: 109658 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/33744506. DOI: 10.1016/j.ejrad.2021.109658.
[39]
GE Y X, JIA Y L, LI Y Z, et al. Synthetic phase-sensitive inversion-recovery vessel for assessing extramural venous invasion in patients with rectal cancer: imaging quality and added value to T2-wighted imaging[J]. Eur Radiol, 2023, 33(6): 4148-4157. DOI: 10.1007/s00330-022-09344-8.
[40]
GONG X L, YE Z, SHEN Y, et al. Enhancing the role of MRI in rectal cancer: advances from staging to prognosis prediction[J]. Eur Radiol, 2025, 35(9): 5714-5732. DOI: 10.1007/s00330-025-11463-x.[LinkOut]
[41]
LIU Y, WEI X Q, FENG X, et al. Repeatability of radiomics studies in colorectal cancer: a systematic review[J/OL]. BMC Gastroenterol, 2023, 23(1): 125 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/37059990. DOI: 10.1186/s12876-023-02743-1.
[42]
SHU Z Y, MAO D W, SONG Q W, et al. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer[J]. Eur Radiol, 2022, 32(2): 1002-1013. DOI: 10.1007/s00330-021-08242-9.
[43]
DING J F, AO W Q, ZHU Z, et al. The value of radiomics based on T2WI and DWI of MRI in preoperative prediction of extramural vascular invasion in rectal cancer[J]. J Diagn Concepts Pract, 2024, 23(1): 46-56. DOI: 10.16150/j.1671-2870.2024.01.007.
[44]
FANG J J, SUN W, WU D, et al. Value of texture analysis based on dynamic contrast-enhanced magnetic resonance imaging in preoperative assessment of extramural venous invasion in rectal cancer[J/OL]. Insights Imaging, 2022, 13(1): 179 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/36417020. DOI: 10.1186/s13244-022-01316-2.
[45]
JAYAPRAKASAM V S, PARODER V, GIBBS P, et al. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer[J]. Eur Radiol, 2022, 32(2): 971-980. DOI: 10.1007/s00330-021-08144-w.
[46]
HE J, TAN X Z, LIN H S, et al. Magnetic resonance imaging-based radiomics of mesorectum for predicting extramural venous invasion in patients with rectal cancer: a bi-centric study[J/OL]. Cancer Imaging, 2026, 26(1): 69 [2026-07-23].https://pubmed.ncbi.nlm.nih.gov/41987267. DOI: 10.1186/s40644-026-01020-0.
[47]
HU T D, GONG J, SUN Y Q, et al. Magnetic resonance imaging-based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study[J/OL]. MedComm, 2024, 5(7): e609 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/38911065. DOI: 10.1002/mco2.609.
[48]
ZHAO B C, WANG J C, MA Z C, et al. Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection[J/OL]. Pathol Oncol Res, 2023, 29: 1611014 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/37151355. DOI: 10.3389/pore.2023.1611014.
[49]
ZHAO L, LIANG M, WANG S C, et al. Preoperative evaluation of extramural venous invasion in rectal cancer using radiomics analysis of relaxation maps from synthetic MRI[J]. Abdom Radiol, 2021, 46(8): 3815-3825. DOI: 10.1007/s00261-021-03021-y.
[50]
TIAN L F, LI N Q, XIE D, et al. Extramural vascular invasion nomogram before radical resection of rectal cancer based on magnetic resonance imaging[J/OL]. Front Oncol, 2022, 12: 1006377 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/36968215. DOI: 10.3389/fonc.2022.1006377.
[51]
CHEN G S, GAO Q, ZHU J W. A study on predictive value of the radiomics nomogram based on multiparametric MRI of the mesorectal fat for extramural venous invasion in rectal cancer[J]. Radiol Pract, 2025, 40(4): 515-522. DOI: 10.13609/j.cnki.1000-0313.2025.04.014.
[52]
LI T X, ZHAO J H. Application of MR-based imaging group in pre-academic evaluation of extramural vascular invasion of rectal cancer[J]. J Clin Radiol, 2025, 44(12): 2401-2406. DOI: 10.3969/j.issn.1001-9324.2025.12.028.
[53]
CAI L S, LAMBREGTS D M J, BEETS G L, et al. An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: A multi-centre study[J/OL]. NPJ Precis Oncol, 2024, 8(1): 17 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/38253770. DOI: 10.1038/s41698-024-00516-x.
[54]
ZHANG Y M, MALI S A, KHAN D, et al. A pre-trained foundation model framework for multiplanar MRI classification of extramural vascular invasion and mesorectal Fascia invasion in rectal cancer[J/OL]. Insights Imaging, 2026, 17(1): 141 [2026-07-23]. https://pubmed.ncbi.nlm.nih.gov/42171860. DOI: 10.1186/s13244-026-02296-3.
[55]
JIANG L Y, SONG Q W, WU C B. Application value of deep learning image reconstruction technology in magnetic resonance scanning of rectal cancer[J]. Zhejiang Clin Med J, 2025, 27(4): 590-592.
[56]
YANG P, TONG N, LI Z, et al. Deep learning-based simulated contrast-enhanced MRI for rectal cancer evaluation: a multicenter study[J]. Abdom Radiol (NY), 2026, 51(7): 3276-3285. DOI: 10.1007/s00261-025-05311-1.
[57]
HUANG H T, YE Y R, YAN L F, et al. Development of an artificial intelligence-based automatic MRI scoring model for extramural vascular invasion in rectal cancer and its prognostic value[J]. Chin J Radiol, 2025, 59(11): 1267-1274. DOI: 10.3760/cma.j.cn112149-20241125-00700.

PREV Research progress of radiomics in predicting treatment response and prognosis of hepatocellular carcinoma after TACE
NEXT Application and advances of magnetic resonance-guided adaptive radiotherapy in uterine malignancies
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn